Financial Toxicity and Societal Costs of Cancer Care: Distinct Problems Require Distinct Solutions

Abstract

Control of societal costs can be addressed through clinician education, value-based guidelines and pathways, formulary restrictions, payment reform, and government regulatory decisions but should not be imposed on patients at the point of decision-making in the cancer clinic.